Drug:
Reaction: ASTHMA
20260101 - 20261231
No. 701 - 800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 701 | 26822918 |
US |
63 | 2 |
Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 702 | 26822924 |
CA |
34 | 2 |
Chest pain, Asthma, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
OMALIZUMAB, RITUXIMAB, CLONAZEPAM, NEOMYCIN OINTMENT, POLYMYXIN B SULFATE, |
||||
| 703 | 26822975 |
US |
2 | |
Asthma, Mast cell activation syndrome, Disturbance in attention, Gastrooesophageal reflux disease, Autonomic nervous system imbalance, Postural orthostatic tachycardia syndrome, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, |
||||
| 704 | 26823278 |
US |
46 | 2 |
Nasopharyngitis, Asthma, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 705 | 26823292 |
US |
54 | 2 |
Asthma, |
||||
DUPILUMAB, OLMESARTAN MEDOXOMIL, |
||||
| 706 | 26823453 |
US |
2 | |
Asthma, Product use complaint, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 707 | 26823664 |
CA |
75 | 1 |
Asthma, Increased bronchial secretion, |
||||
RISANKIZUMAB-RZAA, |
||||
| 708 | 26823683 |
EU |
1 | |
Asthma, Klebsiella test positive, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 709 | 26823743 |
BR |
2 | |
Influenza, Lymphadenopathy, Asthma, Pain, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 710 | 26823780 |
CA |
59 | 2 |
Systemic lupus erythematosus, Pericarditis, Anxiety, Intentional product use issue, Glossodynia, Red blood cell sedimentation rate increased, Product use in unapproved indication, Hepatic enzyme increased, Wound, Treatment failure, Hand deformity, Maternal exposure during pregnancy, Liver injury, Visual impairment, Pain in extremity, Headache, Psoriatic arthropathy, Rash, Asthma, General physical health deterioration, Adverse drug reaction, Diarrhoea, Rheumatoid factor positive, Drug ineffective, Infusion related reaction, Drug intolerance, Mobility decreased, Off label use, Blister, Arthralgia, |
||||
SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, SECUKINUMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CALCIUM CARBONATE, TOFACITINIB, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, AZATHIOPRINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, HYDROCORTISONE, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SARILUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CALCIUM GLUCONATE, CALCIUM GLUCONATE, CERTOLIZUMAB PEGOL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE, MINOCYCLINE, MINOCYCLINE HYDROCHLORIDE, MORPHINE SULFATE, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 711 | 26823977 |
US |
63 | 2 |
Pruritus, Product dose omission issue, Hypersensitivity, Sneezing, Cough, Condition aggravated, Asthma, Skin abrasion, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 712 | 26824038 |
US |
1 | |
Asthma, Pneumonia, Fatigue, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 713 | 26824739 |
US |
79 | 2 |
Spinal fracture, Drug hypersensitivity, Asthma, Scoliosis, |
||||
DENOSUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 714 | 26824862 |
US |
41 | 2 |
Influenza, Migraine, Asthma, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 715 | 26817764 |
US |
61 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 716 | 26817827 |
US |
82 | 2 |
Adverse event, Drug ineffective, Asthma, |
||||
DUPILUMAB, |
||||
| 717 | 26817863 |
US |
2 | |
Asthma, Dizziness, |
||||
DUPILUMAB, |
||||
| 718 | 26817902 |
US |
33 | 1 |
Anxiety, Pain, Asthma, |
||||
DUPILUMAB, |
||||
| 719 | 26818185 |
US |
54 | 2 |
Asthma, Drug ineffective, |
||||
DUPILUMAB, CEFDINIR, |
||||
| 720 | 26818303 |
US |
39 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 721 | 26818317 |
US |
57 | 2 |
Asthma, Surgery, |
||||
DUPILUMAB, |
||||
| 722 | 26818397 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 723 | 26818439 |
US |
77 | 2 |
Asthma, Condition aggravated, Seasonal allergy, |
||||
DUPILUMAB, |
||||
| 724 | 26818472 |
US |
2 | |
Gastrooesophageal reflux disease, Condition aggravated, Asthma, |
||||
DUPILUMAB, |
||||
| 725 | 26818507 |
US |
53 | 2 |
Cough, Aphonia, Chest discomfort, Dyspnoea, Injection site erythema, Sensitivity to weather change, Asthma, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 726 | 26818557 |
US |
72 | 2 |
Asthma, Fatigue, |
||||
DUPILUMAB, |
||||
| 727 | 26818559 |
US |
74 | 1 |
Asthma, Nasal polyps, |
||||
DUPILUMAB, |
||||
| 728 | 26818608 |
US |
12 | 1 |
Viral upper respiratory tract infection, Asthma, Cough, |
||||
DUPILUMAB, |
||||
| 729 | 26818633 |
US |
2 | |
Dyspnoea, Wheezing, Nasal congestion, Influenza, Asthma, Drug ineffective, |
||||
DUPILUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, MEPOLIZUMAB, PREDNISONE, PROGESTERONE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE INHALATION SPRAY, |
||||
| 730 | 26818667 |
US |
10 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 731 | 26818977 |
CA |
65 | 1 |
Death, Arteriosclerosis coronary artery, Antineutrophil cytoplasmic antibody positive, Anxiety, Arteriosclerosis, Capillaritis, Asthma, Conjunctivitis allergic, Dust allergy, Dyspnoea, Condition aggravated, Full blood count abnormal, Eosinophilic granulomatosis with polyangiitis, Forced expiratory volume decreased, Haemoptysis, Hypothyroidism, Hypoxia, Lung disorder, Mite allergy, Mycotic allergy, Neuritis, Neurological symptom, Nodule, Normochromic normocytic anaemia, Obstructive airways disorder, Pain in extremity, Product use in unapproved indication, Productive cough, Pulmonary alveolar haemorrhage, Pulmonary embolism, Pulmonary fibrosis, Pulmonary vasculitis, Respiratory symptom, Sleep disorder, Sleep disorder due to a general medical condition, Therapeutic product effect incomplete, Thrombosis, Total lung capacity abnormal, Vasculitis, Wheezing, Spirometry abnormal, |
||||
CEPHALEXIN, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, APIXABAN, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, BETAMETHASONE DIPROPIONATE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, BUDESONIDE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CARBAMAZEPINE, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CEFUROXIME AXETIL, CICLESONIDE, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, DOXAZOSIN MESYLATE, DUTASTERIDE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, FUROSEMIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MEPOLIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 732 | 26819049 |
US |
2 | |
Bronchitis, Wheezing, Cough, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 733 | 26813061 |
US |
1 | |
Asthma, |
||||
DUPILUMAB, DORNASE ALFA, |
||||
| 734 | 26813071 |
US |
54 | 2 |
Stress, Asthma, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 735 | 26813212 |
US |
52 | 2 |
Leukaemia, Colitis, Rheumatoid arthritis, Asthma, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 736 | 26813260 |
US |
52 | 2 |
Asthma, Off label use, |
||||
DUPILUMAB, |
||||
| 737 | 26813450 |
US |
45 | 2 |
Asthma, Hypersensitivity, Autonomic nervous system imbalance, Adverse drug reaction, Sinus congestion, |
||||
| 738 | 26813534 |
US |
4 | 2 |
Pneumonia, Asthma, Hypersensitivity, Neuromuscular scoliosis, Product dose omission issue, |
||||
TROFINETIDE, |
||||
| 739 | 26813543 |
73 | ||
Pneumonitis, Asthma, Migraine, Cough, Malabsorption, Urticaria, Blood thyroid stimulating hormone increased, Drug ineffective, |
||||
MONTELUKAST, |
||||
| 740 | 26813673 |
CA |
75 | 1 |
Cardiac failure congestive, Pneumonia, Asthma, Full blood count abnormal, Muscle spasms, Sleep disorder due to a general medical condition, Sputum discoloured, Wheezing, Lung disorder, Dyspnoea, Tachycardia, Therapeutic response shortened, Therapeutic product effect incomplete, Chronic obstructive pulmonary disease, Neuropathy peripheral, Paraesthesia, Sensory disturbance, |
||||
MONTELUKAST, MONTELUKAST, ALBUTEROL SULFATE, BENRALIZUMAB, BUDESONIDE, BUDESONIDE, BUPRENORPHINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ROFLUMILAST, DEXLANSOPRAZOLE, GABAPENTIN, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MOMETASONE FUROATE, MOMETASONE, MOXIFLOXACIN HYDROCHLORIDE, MEPOLIZUMAB, OMALIZUMAB, PREDNISONE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, ALBUTEROL SULFATE, ALBUTEROL, MONTELUKAST SODIUM, MONTELUKAST, PANTOPRAZOLE, PREGABALIN, GLYCOPYRROLATE, TIOTROPIUM BROMIDE, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, CALCIUM CARBONATE, |
||||
| 741 | 26813763 |
US |
2 | |
Eczema, Multiple allergies, Asthma, |
||||
DUPILUMAB, |
||||
| 742 | 26813797 |
CA |
||
Anticoagulant therapy, Appendicitis, Appendicolith, Aspartate aminotransferase increased, Blood phosphorus increased, Cardiogenic shock, Cardiovascular disorder, Diabetes mellitus, Hyperlipidaemia, Hyperphosphataemia, Incorrect route of product administration, Multiple organ dysfunction syndrome, Neuralgia, Pleural effusion, Antacid therapy, Blood creatinine increased, Blood uric acid increased, Hyponatraemia, Off label use, Blood test abnormal, Drug hypersensitivity, Dry mouth, Inappropriate schedule of product administration, Ascites, Bronchopulmonary aspergillosis allergic, Condition aggravated, Constipation, Dyspnoea, Intentional product misuse, Lower respiratory tract infection, Thrombosis, Ulcer, Abdominal distension, Analgesic therapy, Benign prostatic hyperplasia, Oedema peripheral, Total lung capacity decreased, Vomiting, Aspiration, Bacterial infection, Blood cholesterol increased, Chronic obstructive pulmonary disease, End stage renal disease, Gout, Hypophosphataemia, Pulmonary embolism, Abdominal pain, Aortic stenosis, Asthma, Blood calcium increased, Death, Drug ineffective, Fatigue, Full blood count abnormal, Product use in unapproved indication, Sleep disorder, Sleep disorder therapy, Ventricular fibrillation, Activated partial thromboplastin time prolonged, Anaemia, Coronary artery disease, General physical health deterioration, Hypertension, Iron deficiency, Liver function test increased, Musculoskeletal stiffness, Myasthenia gravis, Nausea, Somnolence, Troponin increased, |
||||
AMLODIPINE BESYLATE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CALCIUM, CALCIUM CARBONATE, ANTACID, DEXLANSOPRAZOLE, DEXLANSOPRAZOLE, DEXLANSOPRAZOLE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LANSOPRAZOLE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, MESALAMINE, PHYTONADIONE, LANSOPRAZOLE, RAMIPRIL, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, VITAMIN C, VITAMIN C, PHYTONADIONE, |
||||
| 743 | 26813816 |
US |
52 | 2 |
Skin lesion, Asthma, Neurodermatitis, |
||||
DUPILUMAB, |
||||
| 744 | 26814169 |
US |
49 | 2 |
Device leakage, Product dose omission issue, Incorrect dose administered, Pain, Accidental exposure to product, Asthma, Chest discomfort, Peak expiratory flow rate decreased, Cough, Wheezing, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, PREDNISONE, |
||||
| 745 | 26814243 |
US |
2 | |
Asthma, Product ineffective, Product colour issue, |
||||
| 746 | 26814307 |
CA |
43 | |
Abdominal discomfort, Adjustment disorder with depressed mood, Asthma, Chest pain, Contusion, Dyspepsia, Gait inability, Inflammation, Lip dry, Lower respiratory tract infection, Lung disorder, Migraine, Muscle spasms, Paraesthesia, Prescribed underdose, Type 2 diabetes mellitus, Upper respiratory tract infection, Urticaria, Visual impairment, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, Drug-induced liver injury, |
||||
MESALAMINE, AZATHIOPRINE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, DESOXIMETASONE, DESOXIMETASONE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, GOLIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREGABALIN, SALICYLIC ACID, MEDICATED CORN REMOVERS, LIQUID WART REMOVER, ULTRA THIN CORN REMOVERS, EXTRA THICK CALLUS REMOVERS, MEDICATED WART REMOVERS, CORN AND CALLUS REMOVER KIT, WART REMOVERS, WART REMOVER LIQUID, MEDICATED CALLUS REMOVERS, WART REMOVER GEL, MEDICATED PLANTAR WART REMOVER, MEDICATED CALLUS REMOVERS EXTRA THICK, MEDICATED CORN REMOVER, WART REMOVER, CLEAR MEDICATED CORN REMOVERS, CORN REMOVERS, BOSYE BENEFITING HAIR LOTION, LIQUID CORN AND CALLUS REMOVER, WART REMOVER MEDICATED DISCS, WART REMOVER GEL TUBE, SALICYLIC ACID 12%, CALLUS REMOVERS, CORN AND CALLUS REMOVER, GEL CORN REMOVER, ASTRINGENT, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRICLOSAN, USTEKINUMAB, TOFACITINIB, TOFACITINIB, |
||||
| 747 | 26814316 |
US |
63 | 2 |
Muscle fatigue, Abdominal discomfort, Diarrhoea, Asthma, Rebound effect, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 748 | 26814407 |
US |
2 | |
Cardiac failure congestive, Asthma, Expired product administered, Product label issue, |
||||
DAPAGLIFLOZIN, |
||||
| 749 | 26814501 |
CO |
72 | |
Asthma, Tremor, Somnolence, Dyskinesia, Insomnia, |
||||
INSULIN DEGLUDEC AND LIRAGLUTIDE, EMPAGLIFLOZIN, INSULIN GLARGINE, INSULIN GLULISINE, |
||||
| 750 | 26814585 |
US |
18 | 1 |
Eczema, Nasopharyngitis, Asthma, Cough, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 751 | 26814624 |
PR |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 752 | 26814798 |
US |
78 | 2 |
Asthma, Eczema, Muscle spasms, Oral infection, |
||||
| 753 | 26815224 |
GB |
||
Asthma, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 754 | 26815507 |
CA |
66 | 1 |
Hospitalisation, Pneumonia, Cough, Gait disturbance, Dizziness, Myalgia, Asthma, Dyspnoea, Wheezing, Incorrect dose administered, Therapeutic response decreased, |
||||
DUPILUMAB, DUPILUMAB, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, UMECLIDINIUM, TIOTROPIUM BROMIDE, |
||||
| 755 | 26815523 |
US |
38 | 2 |
Asthma, Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 756 | 26815538 |
US |
43 | 2 |
Asthma, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, MONTELUKAST SODIUM, MONTELUKAST, PREDNISONE, TIOTROPIUM BROMIDE INHALATION SPRAY, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, OMALIZUMAB, |
||||
| 757 | 26815569 |
US |
67 | 2 |
Asthma, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, ALBUTEROL SULFATE, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BENZONATATE, BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, ONABOTULINUMTOXINA, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, PANCRELIPASE, DESVENLAFAXINE, DESVENLAFAXINE SUCCINATE, FUROSEMIDE, ATORVASTATIN CALCIUM, LOSARTAN POTASSIUM, LOSARTAN, MIRTAZAPINE, ENSIFENTRINE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, TIZANIDINE, ERGOCALCIFEROL, EZETIMIBE, CETIRIZINE HYDROCHLORIDE, |
||||
| 758 | 26816613 |
US |
34 | 2 |
Anaphylactic reaction, Asthma, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 759 | 26816617 |
US |
10 | 2 |
Asthma, Sleep disorder due to a general medical condition, Product dose omission issue, |
||||
DUPILUMAB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 760 | 26816790 |
US |
2 | |
Intentional overdose, Drug hypersensitivity, Urticaria, Asthma, Wheezing, Bronchospasm, Cough, Insomnia, Illness, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 761 | 26816827 |
47 | 2 | |
Cough, Gastrooesophageal reflux disease, Pain, Asthma, Therapy cessation, Product complaint, Palpitations, |
||||
LISINOPRIL, LEVOTHYROXINE SODIUM, |
||||
| 762 | 26816924 |
UA |
32 | 2 |
Asthma, Nasopharyngitis, Exposure during pregnancy, |
||||
| 763 | 26817045 |
EU |
||
NSAID exacerbated respiratory disease, Contraindicated product administered, Drug intolerance, Chronic rhinosinusitis with nasal polyps, Asthma, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 764 | 26817137 |
US |
1 | |
Asthma, Increased appetite, Weight increased, Dizziness, Rash, |
||||
FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, DUPILUMAB, |
||||
| 765 | 26809080 |
US |
1 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 766 | 26809150 |
US |
58 | |
Asthma, Drug dose omission by device, Wrong technique in product usage process, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 767 | 26809155 |
US |
11 | |
Asthma, Device malfunction, Wrong technique in product usage process performed in error, |
||||
ALBUTEROL SULFATE, |
||||
| 768 | 26809285 |
CA |
79 | 1 |
Pneumonia, Chronic obstructive pulmonary disease, Asthma, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, FLUTICASONE FUROATE, FLUTICASONE FUROATE, MONTELUKAST SODIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, MOMETASONE FUROATE, |
||||
| 769 | 26809457 |
US |
57 | 2 |
Cough, Dyspnoea, Seasonal allergy, Nasopharyngitis, Multiple allergies, Asthma, Dyspnoea, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 770 | 26809697 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage II, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Deep vein thrombosis postoperative, Depression, Diarrhoea, Discomfort, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Ear pain, Epilepsy, Exostosis, Facet joint syndrome, Fatigue, Feeling hot, Fibromyalgia, Folliculitis, Frequent bowel movements, Gait disturbance, Gait inability, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Incorrect route of product administration, Inflammation, Infusion related reaction, Infusion site reaction, Injection site reaction, Injury, Intentional product misuse, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Laboratory test abnormal, Laryngitis, Lip dry, Liver disorder, Liver function test increased, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Lupus-like syndrome, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Neck pain, Night sweats, Obesity, Oedema peripheral, Off label use, Onychomadesis, Onychomycosis, Osteoarthritis, Overlap syndrome, Pain, Pain in extremity, Pancreatitis, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Porphyria acute, Prescribed underdose, Product quality issue, Product use issue, Psoriatic arthropathy, Rash, Rectal haemorrhage, Red blood cell sedimentation rate increased, Respiratory disorder, Rheumatic fever, Rheumatoid arthritis, Road traffic accident, Sciatica, Sinusitis, Sleep disorder, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Therapeutic product effect incomplete, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Ulcer haemorrhage, Underdose, Urticaria, Vomiting, Weight increased, Wheezing, White blood cell count increased, Wound, Wound infection, X-ray abnormal, Maternal exposure timing unspecified, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, |
||||
| 771 | 26809796 |
US |
1 | |
Asthma, Urticaria, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 772 | 26809799 |
AU |
78 | 2 |
Asthma, |
||||
| 773 | 26809858 |
US |
2 | |
Asthma, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 774 | 26809936 |
GB |
70 | 1 |
Asthma, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, |
||||
| 775 | 26810089 |
CA |
1 | |
Blindness, Wound infection, Eye infection, Asthma, Nasopharyngitis, Condition aggravated, Skin laceration, Therapeutic response shortened, Therapeutic response delayed, |
||||
DUPILUMAB, DUPILUMAB, MOMETASONE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ALBUTEROL SULFATE, |
||||
| 776 | 26810158 |
CA |
76 | 2 |
Psoriatic arthropathy, Urinary tract infection, Asthma, Dyspnoea, Psoriasis, Candida infection, Respiratory disorder, Asthenia, |
||||
ADALIMUMAB-RYVK, |
||||
| 777 | 26810294 |
US |
55 | 2 |
Pneumonia, Pulmonary oedema, Asthma, Fatigue, Dry mouth, Sinusitis, Dizziness, Insomnia, Seasonal allergy, Lung disorder, Facial pain, Hypergammaglobulinaemia, Obstructive sleep apnoea syndrome, Obesity, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, OSIMERTINIB, ESCITALOPRAM OXALATE, ESCITALOPRAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, METHOCARBAMOL, METHOCARBAMOL TABLETS, ALBUTEROL SULFATE, GABAPENTIN, MONTELUKAST SODIUM, MONTELUKAST, |
||||
| 778 | 26810837 |
EU |
39 | 2 |
Shrinking lung syndrome, Asthma, Paraplegia, Erythema, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, OXYCODONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, TACROLIMUS, HYDROXYCHLOROQUINE, FOLIC ACID, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE, IVABRADINE, |
||||
| 779 | 26810858 |
US |
44 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 780 | 26810864 |
US |
48 | 2 |
Ocular discomfort, Photophobia, Arthralgia, Asthma, |
||||
DUPILUMAB, |
||||
| 781 | 26810887 |
US |
70 | 2 |
Asthma, Product dose omission issue, |
||||
DUPILUMAB, ORAL SEMAGLUTIDE, |
||||
| 782 | 26811233 |
US |
48 | 2 |
Acute respiratory failure, Arthralgia, Dizziness, Asthma, Pulmonary pain, Chest pain, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, QUETIAPINE FUMARATE, QUETIAPINE, SARILUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CLONIDINE HYDROCHLORIDE, GABAPENTIN, MONTELUKAST SODIUM, MONTELUKAST, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, SULFASALAZINE, SULFASALAZINE, CYANOCOBALAMIN, CETIRIZINE HYDROCHLORIDE, |
||||
| 783 | 26811460 |
US |
69 | 2 |
Hypersensitivity, Asthma, |
||||
DUPILUMAB, |
||||
| 784 | 26811580 |
CA |
65 | 2 |
Pneumonia, Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Oedema, Pain, Respiratory tract infection, Vomiting, Wheezing, |
||||
RITUXIMAB, OMALIZUMAB, OMALIZUMAB, |
||||
| 785 | 26811630 |
31 | 1 | |
Asthma, Dyspnoea, Viral infection, |
||||
TEZEPELUMAB-EKKO, ALBUTEROL SULFATE, ALBUTEROL, LOSARTAN POTASSIUM, LOSARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, PIOGLITAZONE, MONTELUKAST SODIUM, |
||||
| 786 | 26811690 |
US |
63 | 2 |
Cough, Asthma, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 787 | 26811808 |
EU |
39 | 2 |
Paraplegia, Shrinking lung syndrome, Asthma, Erythema, |
||||
DEXAMETHASONE SODIUM PHOSPHATE, PIROXICAM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, OXYCODONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, HYDROXYCHLOROQUINE SULFATE, TIZANIDINE HYDROCHLORIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, FOLIC ACID, |
||||
| 788 | 26812718 |
US |
1 | |
Asthma, Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 789 | 26804125 |
US |
27 | 2 |
Asthma, Dyspnoea, Seizure, Rash, |
||||
DUPILUMAB, |
||||
| 790 | 26804130 |
US |
81 | 2 |
Asthma, Rash, Intentional product misuse, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 791 | 26804242 |
CA |
80 | 1 |
Aspartate aminotransferase increased, Vomiting, Blood phosphorus increased, Sepsis, Lung disorder, Hypertension, Lower respiratory tract infection, Neuralgia, Headache, Ventricular fibrillation, Product dose omission issue, Drug intolerance, Activated partial thromboplastin time prolonged, Asthenia, Appendicolith, Ascites, Respiratory symptom, Incorrect route of product administration, Constipation, Liver disorder, Analgesic therapy, Pulmonary embolism, Joint injury, Congenital hiatus hernia, Transient ischaemic attack, Dry mouth, General physical health deterioration, Hyponatraemia, Anticoagulant therapy, Iron deficiency, Nausea, Blood cholesterol increased, Upper respiratory tract infection, Dyspnoea, Blood uric acid increased, Coronary artery disease, Anaemia, Benign prostatic hyperplasia, Full blood count abnormal, Hyperphosphataemia, Blood test abnormal, Musculoskeletal stiffness, Sleep disorder, Tremor, Antacid therapy, Bacterial infection, Condition aggravated, Gastrointestinal disorder, Malignant melanoma stage 0, Hypercholesterolaemia, Aortic stenosis, Myasthenia gravis, Drug ineffective, Ulcer, Fatigue, Stress, Bronchopulmonary aspergillosis allergic, Abdominal distension, Drug therapy, Intentional product misuse, Chronic obstructive pulmonary disease, Off label use, Swelling, Pleuritic pain, End stage renal disease, Sleep disorder therapy, Cardiogenic shock, Abdominal pain, Product use in unapproved indication, Multiple organ dysfunction syndrome, Breath sounds abnormal, Hyperlipidaemia, Somnolence, Asthma, Diabetes mellitus, Drug hypersensitivity, Troponin increased, Blood calcium increased, Oedema peripheral, Micturition urgency, Cardiovascular disorder, Blood creatinine increased, Appendicitis, Gout, Pain, Transaminases increased, Hypophosphataemia, Thrombosis, Aspiration, Pyrexia, Intentional product misuse, |
||||
AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, ALLOPURINOL SODIUM, ALLOPURINOL SODIUM, ALLOPURINOL SODIUM, ALLOPURINOL SODIUM, DALTEPARIN SODIUM, DALTEPARIN SODIUM, DEXLANSOPRAZOLE, DALTEPARIN SODIUM, DALTEPARIN SODIUM, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, MEPOLIZUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DARBEPOETIN ALFA, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, |
||||
| 792 | 26804735 |
US |
80 | 2 |
Nerve block, Asthma, |
||||
DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BENZONATATE, LORATADINE, LORATADINE TABLET, CLINDAMYCIN HYDROCHLORIDE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, FUROSEMIDE, GLIMEPIRIDE, |
||||
| 793 | 26804771 |
US |
53 | 1 |
Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 794 | 26805202 |
CA |
2 | |
Asthma, Pneumonia, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 795 | 26805330 |
GB |
54 | 1 |
Asthma, |
||||
METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 796 | 26805525 |
US |
1 | |
Illness, Urticaria, Asthma, |
||||
OMALIZUMAB, |
||||
| 797 | 26805527 |
GB |
74 | 1 |
Ameloblastoma, Fatigue, Asthma, |
||||
RAVULIZUMAB, |
||||
| 798 | 26805566 |
US |
41 | 2 |
Joint swelling, Arthralgia, Pain in extremity, Asthma, Fatigue, |
||||
ABATACEPT, |
||||
| 799 | 26805591 |
US |
54 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 800 | 26806114 |
US |
76 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30